•
Jan 31, 2019

Summit Therapeutics Q1 2019 Earnings Report

Total Revenue
$324K
Previous year: $5.33M
-93.9%
EPS
-$0.04
Previous year: -$0.11
-63.6%
Gross Profit
$858K
Cash and Equivalents
$35.2M
Free Cash Flow
-$35.3M
Total Assets
$79.6M

Summit Therapeutics

Summit Therapeutics